DÜSSELDORF, Germany, Dec. 16, 2024 /PRNewswire/ — Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetics industries, announces that the US Food and Drug Administration (FDA) granted SQ Innovation Tentative Approval for Lasix ONYU for the home treatment of fluid overload in congestive heart failure.

The Osseofit devices are intended to match patients’ shoulder bone anatomy and preserve healthy bone in total shoulder replacement procedures.

HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its comprehensive arrhythmia assessment system.

Withings Health Solutions announced today that it received FDA clearance for BPM Pro 2, a first-of-its-kind cellular blood pressure monitor.